Zdrowie i gospodarka · 10/02/2023
FDA Announces Draft Guidance for Infant Formula Manufacturers on Protein Efficiency Ratio (PER) Bioassay Studies
The FDA is releasing a draft guidance to help manufacturers and laboratories design and conduct studies to demonstrate the protein quality of new infant formulas, with the aim of supporting the quality factor of sufficient biological quality of protein.